Francesca Norman

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

François-Xavier Lescure, Hitoshi Honda, Robert Fowler et al. · The Lancet Respiratory Medicine · 2021 · 248 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

Ca-125: A Useful Marker to Distinguish Pulmonary Tuberculosis from Other Pulmonary Infections

Jesús Fortün, Pilar Martín‐Dávila, Robert Mendez et al. · The Open Respiratory Medicine Journal · 2009 · 176 citations · Full text

Medicine, Pathology, Clinical Biochemistry +10

Old and new challenges in Chagas disease

José A. Pérez‐Molina, Angela Martinez Perez, Francesca Norman et al. · The Lancet Infectious Diseases · 2015 · 109 citations

Veterinary Medicine, Biology, Infectious Diseases +14

Imported Infectious Diseases in Mobile Populations, Spain

Begoña Monge‐Maíllo, Beatriz C. Jiménez, José A. Pérez‐Molina et al. · Emerging infectious diseases · 2009 · 105 citations · Full text

Veterinary Medicine, Infectious Diseases, Population Health Sciences +16

Chagas Disease in Non-Endemic Countries: Epidemiology, Clinical Presentation and Treatment

José A. Pérez‐Molina, Francesca Norman, Rogelio López‐Vélez · Current Infectious Disease Reports · 2012 · 98 citations

Veterinary Medicine, Infectious Diseases, Pathobiology +16